Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
McKinsey
Moodys
Harvard Business School
Baxter

Last Updated: August 19, 2022

TOLAK Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


When do Tolak patents expire, and when can generic versions of Tolak launch?

Tolak is a drug marketed by Hill Dermaceuticals and is included in one NDA. There is one patent protecting this drug.

This drug has three patent family members in three countries.

The generic ingredient in TOLAK is fluorouracil. There are fifteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the fluorouracil profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Tolak

A generic version of TOLAK was approved as fluorouracil by FRESENIUS KABI USA on September 30th, 1998.

  Try it Free

US Patents and Regulatory Information for TOLAK

TOLAK is protected by one US patents.

Patents protecting TOLAK

Topical skin care composition containing refined peanut oil
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hill Dermaceuticals TOLAK fluorouracil CREAM;TOPICAL 022259-001 Sep 18, 2015 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for TOLAK

See the table below for patents covering TOLAK around the world.

Country Patent Number Title Estimated Expiration
European Patent Office 1696868 COMPOSITION TOPIQUE DE SOINS DE LA PEAU CONTENANT DE L'HUILE DE CACAHUETES RAFFINEE (TOPICAL SKIN CARE COMPOSITION CONTAINING REFINED PEANUT OIL) See Plans and Pricing
World Intellectual Property Organization (WIPO) 2005009406 See Plans and Pricing
Canada 2541373 COMPOSITION TOPIQUE DE SOINS DE LA PEAU CONTENANT DE L'HUILEDE CACAHUETES RAFFINEE (TOPICAL SKIN CARE COMPOSITION CONTAINING REFINED PEANUT OIL) See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Moodys
McKinsey
Express Scripts
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.